Regulatory and safety challenges of biosimilars: insights from developed and emerging economies
Crossref DOI link: https://doi.org/10.1007/s00228-026-04053-3
Published Online: 2026-04-15
Published Print: 2026-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Haritwal, Prerna
Lohani, Alka
Text and Data Mining valid from 2026-04-15
Version of Record valid from 2026-04-15
Article History
Received: 25 November 2025
Accepted: 3 April 2026
First Online: 15 April 2026
Declarations
:
: Not applicable.
: The authors declare no competing interests.